Core Viewpoint - As of September 5, 2025, Kangtong Medical (301515) closed at 21.56 yuan, reflecting a 1.27% increase, with a trading volume of 10,600 shares and a total transaction value of 22.67 million yuan [1] Financial Performance - The company reported a main revenue of 265 million yuan for the first half of 2025, a year-on-year decrease of 39.29% [3] - The net profit attributable to shareholders was -8.40 million yuan, down 154.53% year-on-year [3] - The second quarter of 2025 saw a single-quarter main revenue of 241 million yuan, a decline of 33.22% year-on-year [3] - The company’s gross profit margin stood at 22.09%, significantly lower than the industry average of 51.85% [3] Market Position - Kangtong Medical's total market capitalization is 2.156 billion yuan, ranking 118th in the medical device industry [3] - The company has a net asset value of 1.217 billion yuan, ranking 97th in the industry [3] - The price-to-earnings ratio (P/E) is -128.27, indicating negative earnings, while the industry average is 65.4 [3] Capital Flow Analysis - On September 5, 2025, the net outflow of main funds was 60,200 yuan, accounting for 0.27% of the total transaction value [2] - Retail investors experienced a net outflow of 999,000 yuan, representing 4.41% of the total transaction value [2] - In the past five days, the stock has seen fluctuations in capital flow, with notable net inflows and outflows from both institutional and retail investors [2]
股票行情快报：港通医疗（301515）9月5日主力资金净卖出6.02万元